Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Futures
Economy
Global Metrics

Bellicum Pharmaceuticals Shares Outstanding 2013-2019 | BLCM

Bellicum Pharmaceuticals shares outstanding from 2013 to 2019. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
  
Bellicum Pharmaceuticals Annual Shares Outstanding
(Millions of Shares)
2018 40
2017 32
2016 27
2015 26
2014 3
2013 2
2012 2
Bellicum Pharmaceuticals Quarterly Shares Outstanding
(Millions of Shares)
Q2 2019 46
Q1 2019 44
Q4 2018 40
Q3 2018 43
Q2 2018 41
Q1 2018 33
Q4 2017 33
Q3 2017 33
Q2 2017 33
Q1 2017 27
Q4 2016 27
Q3 2016 27
Q2 2016 27
Q1 2016 27
Q4 2015 26
Q3 2015 26
Q2 2015 26
Q1 2015 26
Q4 2014 4
Q3 2014 2
Q2 2014 2
Q1 2014 2
Q4 2013
Q4 2012
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.046B $0.001B
Bellicum Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. It is focused on discovering and developing cellular immunotherapies for various forms of cancer, including both hematological and solid tumors, as well as orphan inherited blood disorders. The Company's lead clinical product candidate is BPX-501, an adjunct T-cell therapy in multiple Phase I/II clinical trials. It is also developing BPX-201, a dendritic cell cancer vaccine, which is in a Phase I clinical trial for the treatment of metastatic castrate-resistant prostate cancer. Bellicum Pharmaceuticals, Inc. is based in Houston, Texas.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $59.871B 36.87
Astellas Pharma (ALPMY) Japan $26.681B 13.08
Takeda Pharmaceutical (TAK) Japan $26.123B 8.16
Grifols, S.A (GRFS) Spain $15.119B 19.29
UCB SA (UCBJF) Belgium $15.008B 0.00
Eisai (ESALY) Japan $14.535B 24.99
Merck (MKGAF) Germany $13.648B 18.62
Ionis Pharmaceuticals (IONS) United States $9.706B 20.93
Ono Pharmaceutical (OPHLF) Japan $9.383B 20.06
Neurocrine Biosciences (NBIX) United States $8.905B 0.00
IPSEN SA ADR (IPSEY) France $8.570B 0.00
Sage Therapeutics (SAGE) United States $8.368B 0.00
Catalent (CTLT) United States $8.137B 32.65
Jazz Pharmaceuticals (JAZZ) Ireland $7.634B 10.05
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $7.257B 19.83
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.781B 0.00
STADA ARZNEIMI (STDAF) Germany $5.547B 0.00
Orion OYJ (ORINY) Finland $5.275B 27.16
Hypermarcas (HYPMY) Brazil $4.913B 17.66
FibroGen (FGEN) United States $3.876B 96.96
United Therapeutics (UTHR) United States $3.568B 0.00
Nektar Therapeutics (NKTR) United States $3.172B 0.00
Taro Pharmaceutical Industries (TARO) Israel $3.143B 11.27
Evotec AG (EVTCY) Germany $3.127B 42.81
Tilray (TLRY) Canada $3.044B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $2.957B 67.80
PTC Therapeutics (PTCT) United States $2.660B 0.00
Xencor (XNCR) United States $2.306B 50.28
Zogenix (ZGNX) United States $2.111B 0.00
Portola Pharmaceuticals (PTLA) United States $2.078B 0.00
Pacira Pharmaceuticals (PCRX) United States $1.591B 57.91
CLINIGEN GP (CLIGF) United Kingdom $1.577B 0.00
USANA Health Sciences (USNA) United States $1.500B 15.05
Corcept Therapeutics (CORT) United States $1.477B 20.30
Enanta Pharmaceuticals (ENTA) United States $1.416B 23.35
Ironwood Pharmaceuticals (IRWD) United States $1.372B 0.00
Heron Therapeutics (HRTX) United States $1.371B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.204B 0.00
ArQule (ARQL) United States $1.078B 0.00
Radius Health (RDUS) United States $1.066B 0.00
Aerie Pharmaceuticals (AERI) United States $1.065B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.904B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $0.724B 3.23
TherapeuticsMD (TXMD) United States $0.690B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.593B 0.00
Karyopharm Therapeutics (KPTI) United States $0.562B 0.00
Akebia Therapeutics (AKBA) United States $0.559B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.542B 0.00
Concordia (CXRXF) Canada $0.533B 0.00
Endo (ENDP) Ireland $0.512B 0.90
Indivior (INVVY) United States $0.487B 1.76
Aptorum Group (APM) China $0.472B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.453B 0.00
Dermira (DERM) United States $0.448B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.431B 19.58
ImmunoGen (IMGN) United States $0.424B 0.00
Siga Technologies (SIGA) United States $0.421B 0.98
Organogenesis Holdings (ORGO) United States $0.421B 0.00
Flexion Therapeutics (FLXN) United States $0.419B 0.00
Dova Pharmaceuticals (DOVA) United States $0.418B 0.00
Translate Bio (TBIO) United States $0.415B 0.00
ChemoCentryx (CCXI) United States $0.390B 0.00
Collegium Pharmaceutical (COLL) United States $0.386B 0.00
Innate Pharma SA (IPHYF) France $0.374B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.368B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.325B 0.00
CV Sciences (CVSI) United States $0.317B 0.00
Xeris Pharmaceuticals (XERS) United States $0.313B 0.00
CannTrust Holdings (CTST) Canada $0.297B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.286B 0.00
Rafael Holdings (RFL) United States $0.285B 0.00
KalVista Pharmaceuticals (KALV) United States $0.285B 0.00
Harpoon Therapeutics (HARP) United States $0.283B 0.00
Lannett Co Inc (LCI) United States $0.266B 2.58
La Jolla Pharmaceutical (LJPC) United States $0.265B 0.00
OptiNose (OPTN) United States $0.263B 0.00
DURECT (DRRX) United States $0.261B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.252B 0.00
Concert Pharmaceuticals (CNCE) United States $0.249B 0.00
Recro Pharma (REPH) United States $0.242B 0.00
Calithera Biosciences (CALA) United States $0.216B 0.00
Ocular Therapeutix (OCUL) United States $0.211B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.189B 0.00
Molecular Templates (MTEM) United States $0.187B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.180B 0.00
Nature's Sunshine Products (NATR) United States $0.174B 29.03
Taiwan Liposome (TLC) Taiwan $0.165B 0.00
IMV INC (IMV) Canada $0.157B 0.00
Ardelyx (ARDX) United States $0.155B 0.00
Redhill Biopharma (RDHL) Israel $0.151B 0.00
GlycoMimetics (GLYC) United States $0.147B 0.00
Jounce Therapeutics (JNCE) United States $0.131B 0.00
Generex Biotechnology (GNBT) United States $0.128B 0.00
Majesco Entertainment (PTE) United States $0.121B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.117B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.114B 0.00
Oasmia Pharmaceutical AB (OASM) Sweden $0.112B 0.00
MEI Pharma (MEIP) United States $0.110B 0.00
AgeX Therapeutics (AGE) United States $0.108B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.108B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.108B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.105B 0.00
Aquestive Therapeutics (AQST) United States $0.095B 0.00
Iterum Therapeutics (ITRM) Ireland $0.094B 0.00
Neos Therapeutics (NEOS) United States $0.092B 0.00
Mast Therapeutics (SVRA) United States $0.091B 0.00
Cardiome Pharma (CORV) Canada $0.089B 0.00
Nivalis Therapeutics (ALPN) United States $0.088B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.087B 33.11
Genocea Biosciences (GNCA) United States $0.082B 0.00
RENEURON GP (RNUGF) United Kingdom $0.080B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.077B 0.00
Natural Alternatives (NAII) United States $0.075B 7.54
MediWound (MDWD) Israel $0.074B 0.00
Champions Oncology (CSBR) United States $0.072B 618.00
China SXT Pharmaceuticals (SXTC) China $0.071B 0.00
Infinity Pharmaceuticals (INFI) United States $0.070B 0.00
Otonomy (OTIC) United States $0.069B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.066B 0.00
Capnia (SLNO) United States $0.064B 0.00
Novan (NOVN) United States $0.063B 0.00
SCYNEXIS (SCYX) United States $0.060B 0.00
Pharmaxis (PXSLY) Australia $0.060B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.059B 0.00
Lipocine (LPCN) United States $0.058B 0.00
Medicure (MCUJF) Canada $0.053B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.050B 0.00
ElectroCore (ECOR) United States $0.049B 0.00
Forward Pharma (FWP) Denmark $0.043B 0.00
India Globalization Capital (IGC) United States $0.042B 0.00
CTI BioPharma (CTIC) United States $0.038B 0.00
Aclaris Therapeutics (ACRS) United States $0.036B 0.00
Mannatechorporated (MTEX) United States $0.035B 0.00
Bio-Path Holdings (BPTH) United States $0.035B 0.00
Melinta Therapeutics (MLNT) United States $0.032B 0.00
PharmAthene (ALT) United States $0.031B 0.00
Biomerica (BMRA) United States $0.031B 0.00
ProPhase Labs (PRPH) United States $0.023B 0.00
IsoRay (ISR) United States $0.022B 0.00
Opexa Therapeutics (ACER) United States $0.021B 0.00
Heat Biologics (HTBX) United States $0.019B 0.00
HANCOCK JAFFE (HJLI) United States $0.018B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.018B 1.41
Tetraphase Pharmaceuticals (TTPH) United States $0.016B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.015B 0.00
Achieve Life Sciences (ACHV) United States $0.015B 0.00
Cyanotech (CYAN) United States $0.014B 0.00
Shineco (TYHT) China $0.014B 0.00
Onconova Therapeutics (ONTX) United States $0.013B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.012B 0.00
Regulus Therapeutics (RGLS) United States $0.012B 0.00
VAXART, INC (VXRT) United States $0.010B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.009B 0.00
RXi Pharmaceuticals (PHIO) United States $0.009B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.008B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.006B 0.00
Jaguar Animal Health (JAGX) United States $0.006B 0.00
Flex Pharma (SLRX) United States $0.005B 0.00
Midatech Pharma (MTP) United Kingdom $0.004B 0.00
Can-Fite Biopharma (CANF) Israel $0.003B 0.00
Xenetic Biosciences (XBIO) United States $0.002B 0.00
Advanced Accelerator Applications S.A (AAAP) France $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00